Biogen
Total capacity of implemented projects
50 - 250 MW
Countries of projects presence
2
Biogen is a biotech company based in the United States that specializes in the development of treatments for neurological and neurodegenerative diseases, hemophilia, and autoimmune disorders. The company was founded in 1978 and has since become a leader in the biotech industry, with a focus on innovation, sustainability, and corporate responsibility.
One of Biogen's key priorities is decarbonisation, which refers to the reduction of carbon emissions in order to combat climate change. The company has set ambitious targets to reduce its carbon footprint and has implemented a range of initiatives to achieve these goals. For example, Biogen has invested in renewable energy sources such as solar and wind power, which has allowed the company to reduce its reliance on fossil fuels and decrease its carbon emissions.
In addition to investing in renewable energy, Biogen has also implemented a corporate energy strategy that focuses on energy efficiency and conservation. This strategy includes measures such as upgrading lighting and HVAC systems, optimizing energy usage in manufacturing processes, and implementing energy management systems to monitor and control energy consumption. By reducing its energy usage, Biogen is able to lower its carbon footprint and reduce its environmental impact.
Another key initiative that Biogen has undertaken to promote sustainability is the use of corporate power purchase agreements (PPAs) for renewable energy. A PPA is a contract between a company and a renewable energy provider, in which the company agrees to purchase a certain amount of renewable energy at a fixed price over a specified period of time. By using PPAs, Biogen is able to support the development of renewable energy projects and increase the proportion of renewable energy in its overall energy mix.
Overall, Biogen's commitment to sustainability and decarbonisation is reflected in its corporate culture and business practices. The company has set ambitious targets to reduce its carbon footprint and has implemented a range of initiatives to achieve these goals. By investing in renewable energy, implementing energy efficiency measures, and using corporate PPAs for renewable energy, Biogen is demonstrating its commitment to sustainability and corporate responsibility.
In addition to its sustainability initiatives, Biogen is also a leader in the biotech industry, with a focus on innovation and the development of new treatments for neurological and neurodegenerative diseases, hemophilia, and autoimmune disorders. The company has a strong pipeline of products in development, including several potential treatments for Alzheimer's disease, which is a major unmet medical need.
Biogen's success in the biotech industry is due in large part to its focus on innovation and collaboration. The company has a strong research and development program, with a team of scientists and researchers who are dedicated to discovering new treatments and therapies. Biogen also collaborates with academic institutions, other biotech companies, and government agencies to advance scientific knowledge and develop new treatments.
In addition to its focus on innovation, Biogen is also committed to corporate responsibility and ethical business practices. The company has a code of conduct that outlines its commitment to ethical behavior, and it has implemented a range of initiatives to promote diversity, equity, and inclusion in the workplace. Biogen also has a strong philanthropic program, with a focus on supporting organizations that promote health and wellness, education, and community development.
Overall, Biogen is a leading biotech company that is committed to sustainability, innovation, and corporate responsibility. The company's focus on decarbonisation, corporate energy, corporate PPAs, and renewable energy reflects its commitment to reducing its environmental impact and promoting sustainability. With a strong pipeline of products in development and a commitment to ethical business practices, Biogen is well positioned to continue its success in the biotech industry and make a positive impact on society.